Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.29 USD | +2.24% | +20.65% | +0.17% |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
May. 02 | Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85 | MT |
Official Publications
SEC Filing 10Q-2 | CO | |
Dividends | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 4K | CO | |
Dividends | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Changes in management and corporate officers | CO | |
Provisional calendar | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-3 | CO | |
Dividends | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Official Publications